Skip to main navigation Skip to search Skip to main content

Dicer1-miR-328-Bace1 signalling controls brown adipose tissue differentiation and function

  • Matteo Oliverio
  • , Elena Schmidt
  • , Jan Mauer
  • , Catherina Baitzel
  • , Nils Hansmeier
  • , Sajjad Khani
  • , Sandra Konieczka
  • , Marta Pradas-Juni
  • , Susanne Brodesser
  • , Trieu My Van
  • , Deniz Bartsch
  • , Hella S. Brönneke
  • , Markus Heine
  • , Hans Hilpert
  • , Emilio Tarcitano
  • , George A. Garinis
  • , Peter Frommolt
  • , Joerg Heeren
  • , Marcelo A. Mori
  • , Jens C. Brüning
  • Jan Wilhelm Kornfeld

Research output: Contribution to journalArticlepeer-review

Abstract

Activation of brown adipose tissue (BAT) controls energy homeostasis in rodents and humans and has emerged as an innovative strategy for the treatment of obesity and type 2 diabetes mellitus. Here we show that ageing-and obesity-associated dysfunction of brown fat coincides with global microRNA downregulation due to reduced expression of the microRNA-processing node Dicer1. Consequently, heterozygosity of Dicer1 in BAT aggravated diet-induced-obesity (DIO)-evoked deterioration of glucose metabolism. Analyses of differential microRNA expression during preadipocyte commitment and mouse models of progeria, longevity and DIO identified miR-328 as a regulator of BAT differentiation. Reducing miR-328 blocked preadipocyte commitment, whereas miR-328 overexpression instigated BAT differentiation and impaired muscle progenitor commitment-partly through silencing of the β-secretase Bace1. Loss of Bace1 enhanced brown preadipocyte specification in vitro and was overexpressed in BAT of obese and progeroid mice. In vivo Bace1 inhibition delayed DIO-induced weight gain and improved glucose tolerance and insulin sensitivity. These experiments reveal Dicer1-miR-328-Bace1 signalling as a determinant of BAT function, and highlight the potential of Bace1 inhibition as a therapeutic approach to improve not only neurodegenerative diseases but also ageing-and obesity-associated impairments of BAT function.

Original languageEnglish (US)
Pages (from-to)328-336
Number of pages9
JournalNature Cell Biology
Volume18
Issue number3
DOIs
StatePublished - Feb 25 2016
Externally publishedYes

Bibliographical note

Funding Information:
We thank B. Hampel, A. Schauss, H. Jacobsen, J. Altmüller and J. Alber for technical assistance and A. Tarakhovsky (Rockefeller University, USA) for providing Dicer1loxP/loxP mice. We are grateful for Amesdf mice from A. Bartke (Southern Illinois University School of Medicine, USA). J.-W.K., M.O., N.H. and S.Konieczka are supported by the Emmy-Noether Program (DFG; KO4728/1.1) and CECAD. E.S. is supported by Evangelisches Studienwerk Villigst. S.Khani appreciates support from DAAD. E.T. and M.A.M. are supported by CNPq, CAPES and FAPESP (2010/52557- 0). J.C.B. is supported by the Leibniz Preis (BR1492/7-1), CECAD, Cologne Center for Molecular Medicine Cologne (CMMC) and through financial support from ''Systems Biology of Ageing Cologne'' (Sybacol).

Publisher Copyright:
© 2016 Macmillan Publishers Limited.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Dicer1-miR-328-Bace1 signalling controls brown adipose tissue differentiation and function'. Together they form a unique fingerprint.

Cite this